Teva Pharmaceuticals Israel lab backed by pharma giants mints startup for computer-designed antibodies
Teva Pharmaceuticals Investors Worldwide Agreed to Class Action Litigation Settlements Totaling More than $7.4 Billion in 2022
Teva Pharmaceuticals 2023 forecast: An 'inflection point' for biopharma, fueled by a flood of AI and machine learning products
Teva Pharmaceuticals Executive Conversations: Using AI and ML to accelerate joint learning in pharmaceuticals with consortium members of AION Labs
